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Abstract  
Context: Diabetic ketoacidosis (DKA) is a well-known emergency in diabetic patients. In a subgroup of patients 
ketoacidosis is present but is not accompanied by the marked hyperglycemia considered part of the diagnostic 
criteria for DKA. This is known as Euglycemic DKA (EuDKA).  
Evidence acquisition: We searched the PubMed for the existing literature on the topic of normoglymic 
ketoacidosis, including its prevalence, pathogenesis, and treatment.   
Results: The study showed that there are many reports of the cases in which diabetic patients developed 
ketoacidosis without experiencing hyperglycemia. Several predisposing factors have been proposed but the 
precise pathophysiologic mechanisms are still under investigation. Some pathways have been suggested. 
Timely diagnosis is of paramount importance. Treatment is similar to DKA.  
Conclusion: EuDKA is a medical emergency that should be considered when evaluating a diabetic patient with 
ketoacidosis. It should be diagnosed and treated promptly. 
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CONTEXT  
Hyperglycemia crisis, either in the form of 
hyperglycemic, hyperosmolar state or diabetic 
ketoacidosis (DKA), is an acute complication of 
diabetes mellitus frequently seen in the emergency 
departments.   
DKA, one of the gravest complications of diabetes 
mellitus, is characterized by the triad of 
hyperglycemia (plasma glucose >250 mg/dl), 
metabolic acidosis (arterial pH <7.3 and serum 
bicarbonate less than18 mEq/L) typically with a 
wide anion gap, and ketosis (1-3). At present, 
mortality attributable to DKA is fairly low, but in 
some groups, such as patients of higher age and 
those with several episodes of DKA, the mortality 
may still be high (1, 3). Moreover, in children with 
type 1 diabetes mellitus, DKA is still one of the main 
causes of mortality (3). It is often precipitated by 
factors such as infections, insufficient insulin 
therapy (inadequate dose or discontinuation of 
treatment), pancreatitis, myocardial infarction, 
cerebrovascular accident, or illicit drug use (1, 2, 
4). 
Although hyperglycemia is a fundamental criterion 
for diagnosis of DKA, in practice, plasma glucose 
levels on admission can vary across a wide range 
(5). DKA patients may be encountered with blood 
glucose levels below 200 mg/dl. Although this 
condition may be considered as a less severe 
variant of DKA, the reported in-hospital mortality 
rate of patients with EuDKA is similar to that of 
cases with typical DKA (2, 3).  
Euglycemic diabetic ketoacidosis (EuDKA), defined 
as DKA without marked hyperglycaemia (<200 
mg/dL), was first described by Munro in 1973 (2, 
4, 6). This condition is considered to be relatively 
uncommon, but may in fact be underreported (4). 
More formally, EuDKA is defined as a triad of wide 
anion gap metabolic acidosis, ketonemia and 
ketonuria, and a plasma glucose level lower than 
200 mg/dL (1, 7). 
EVIDENCE ACQUISITION 
We searched the literature for reports on EuDKA, 
using the keywords ketoacidosis, normoglycemic, 
euglycemic, hyperglycemic crisis, and diabetic 
emergencies, using PubMed. We also we extracted 
the references the retrieved articles and reviewed 
them for relevant information. 
RESULTS 
Pathogenesis 
EuDKA is particularly encountered in patients 
suffering from type 1 diabetes in the context of 
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starvation in conjunction with an inter-current 
illness (4). However, it may also be encountered in 
patients with type 2 diabetes (8). The incidence of 
EuDKA in the latter type is on increase with the use 
of sodium-glucose cotransporter 2 (SGLT2) 
inhibitors (9). Predisposing factors associated with 
the occurrence of EuDKA in patients taking SGLT2 
inhibitors include surgery, low carbohydrate 
regimen, insulin cessation or dose reduction, acute 
medical illness, and latent autoimmune diabetes of 
adulthood (10-12)  
The main anabolic hormone, insulin, causes 
glycogenesis, lipogenesis, and proteogenesis. It 
also increases peripheral glucose consumption. 
Counter-regulatory hormones (CRHs) including 
glucagon, growth hormone, glucocorticoids, and 
cathecolamines oppose the action of insulin and 
also decrease peripheral insulin sensitivity (10, 
13). Insulin deficiency, either absolute or relative, 
in tandem with elevated levels of CRHs, gives rise 
to DKA. Shortage of insulin results in 
glycogenolysis, lipolysis, and proteolysis. Increased 
glucagon leads to oxidation of free fatty acids and 
production of keton bodies. Keton bodies are 
strong acids and in large quantities create 
metabolic acidosis. Glycogenolysis resulting from 
insulin deficiency and abundance of CRHs causes 
hyperglycemia (10). In the presence of prolonged 
fasting or starvation, hepatic glycogen stores are 
depleted. Therefore, lipolysis and ketoacidosis 
occur as a result of inadequate insulin levels and 
increased CRH levels, but lack of glycogen stores 
prevents from pronounced hyperglycemia. EuDKA 
then ensues. The magnitude of insulin deficiency 
and insulin resistance is generally smaller, thus 
there is a less pronounced increase in glucose 
production and reduction in glucose consumption. 
Furthermore, glucose clearance in EuDKA is twice 
as much as in DKA, an effect mediated through 
CRHs (9). 
Nausea or vomiting, either due to ketoacidosis 
itself or resulting from a precipitating illness, 
usually leads to a decline in caloric intake and 
inadequate hydration. Under these circumstances, 
if the patient continues to use sufficient quantities 
of insulin, insulin suppresses hepatic production of 
glucose and results in low serum glucose levels, 
while not capable of stopping the formation of 
ketone bodies (1, 2, 4).  This, in turn, causes DKA 
with mildly elevated levels of serum glucose or 
even relatively normal serum glucose. In situations 
where the patient experiences a prolonged fasting, 
depletion of glycogen stores of the liver (resulting 
from increased secretion of CRHs especially 
glucagon) contributes to the state of normal serum 
glucose levels while metabolic acidosis builds up 
(8-10). On the other hand, dehydration triggers 
secretion of glucagon with subsequent lipolysis 
and production of free fatty acid (10). During 
fasting, insulin is less capable of lipolysis and 
ketogenesis suppression, which then exacerbates 
acidosis and excessive ketone body production (10, 
11, 14, 15).  
Secretion of CRHs are increased in the presence of 
dehydration, further worsening the EuDKA. The 
following situations have so far been reported in 
the literature as the causes of EuDKA: low caloric 
intake, fasting or starvation, bariatric surgery, 
dehydration, pregnancy, pancreatitis, glycogen 
storage diseases, cocaine intoxication, 
consumption of large amounts of alcohol, chronic 
liver disease, prolonged vomiting or diarrhea, and 
insulin pump use (7, 16).  
During pregnancy, lipolysis and ketone body 
production is increased during pregnancy while 
insulin sensitivity is decreased (17). Moreover, in 
the second and third trimesters of pregnancy, 
maternal glucose is consumed in large quantities as 
the main source of energy by both the fetus and the 
placenta, creating a state of accelerated starvation. 
This, in turn, leads to decreased fasting plasma 
glucose in the mother. Increased production of free 
fatty acids resulting from relative insulin deficiency 
occurs. These fatty acids then transported to the 
liver and are converted to ketones (10, 18). The 
pregnancy-induced respiratory alkalosis leads to 
an increased excretion of bicarbonate through 
urine. Therefore, the body loses its ability to buffer 
changes in pH which is caused by increased 
production of body ketones (15, 19). This leads to 
EuDKA in pregnancy. 
As mentioned earlier, the recent use of SGLT2 
inhibitors has also been mentioned as the 
precipitating cause of EuDKA. This finding has 
helped us understand another possible mechanism 
of EuDKA. SGLT2 inhibitors (such as Canaglifluzin, 
Dapaglifluzin, Empaglifluzin, Tofoglifluzin, 
Luseoglifluzin) prevent the reabsorption of glucose 
in the kidney at the proximal renal tubules, 
promoting its excretion in the urine. A possible 
mechanism for SGLT2 inhibitors-related EuDKA is 
through increasing urinary glucose excretion, and 
the resultant reduction of insulin secretion from 
pancreatic beta cells. Decreased circulating insulin 
level enhances the production of free fatty acids, 
which are then transformed into ketone bodies by 
the liver (20). Moreover, SGLT2 inhibitors 
stimulate glucagon secretion. This action is exerted 
either directly by effect of SGLT2 inhibitors on 
pancreatic α-cells, or indirectly through a decrease 
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in insulin secretion. Recent evidence has 
demonstrated that SGLT2 are present in pancreatic 
α-cells (11). Increased secretion of glucagon also 
leads to the overproduction of ketone bodies. 
Therefore, treatment with SGLT2 inhibitors reduce 
the insulin-to-glucagon ratio, exacerbating 
ketogenesis, gluconeogenesis, and glycogenolysis 
(12, 14). Figure 1 illustrate a summary of the 
pathophysiologic mechanisms of EuDKA. 
Diagnosis 
EuDKA is a medical emergency which needs to be 
diagnosed and treated quickly and appropriately 
(7). Diagnosis of EuDKA is difficult and poses a 
challenge to physicians. This diagnosis can easily 
be delayed or even missed due to low plasma 
glucose levels (1, 4), which may lead to disastrous 
consequences. Successful diagnosis of EuDKA 
requires a high index of suspicion. Potential 
triggers of EDKA should be born in mind when 
visiting susceptible patients and other differential 
diagnosis should be actively ruled out (4, 7). In 
patients with unexplained acidosis, serum ketone 
levels should be obtained and differential 
diagnoses should be born in mind.   
EuDKA is primarily a diagnosis of exclusion (2, 3, 
5). It should be distinguished from other causes of 
ketoacidosis in which plasma glucose is normal. 
These include starvation ketoacidosis and alcoholic 
ketoacidosis (AKA). The differentiation can be 
made through clinical assessment and serum 
bicarbonate levels.  
Starvation ketoacidosis (SKA) is a rare cause of 
acid-base disturbance presenting as severe 
metabolic acidosis following prolonged fasting. In 
an otherwise-healthy individual, a 12- to 14-hour 
fast usually increases ketone body production 
resulting in mild ketosis without significant change 
in serum pH. The pH almost invariably remains 
above 7.30 (21, 22). Under conditions of 
physiologic stress or when body’s glucose 
requirement is increased (e.g. during pregnancy, 
severe depression, in the elderly, and in young 
infants), prolonged fasting may lead to a severe 
acid-base disturbances (21, 23). 
During starvation, plasma glucose concentration 
decreases, accompanied by reduced levels of serum 
insulin and elevated levels of serum glucagon. A 
depletion of hepatic glycogen stores then follows. 
Decreased insulin enhances lipase activity, which 
converts triglyceride into free fatty acid chains. 
Free fatty acids are then metabolized in the liver to 
form keton bodies. This amount of ketones exceeds 
the quantities that the body can use as a source of 
energy, leading to a state of pathological ketosis. 
SKA is diagnosed based on the following criteria: 
history of diminished caloric intake, low glucose 
concentration in plasma, the presence of 
ketonaemia or ketonuria, and a high serum beta-
hydroxybutyrate level (21, 22). 
AKA is an acute metabolic disorder. Typical patient 
is a chronic alcohol abuser who went on a recent 
binge and abruptly terminated eating owing to 
 
Figure 1: Summery of pathophysiologic mechanisms of EuDKA 
 
ADVANCED JOURNAL OF EMERGENCY MEDICINE. 2020;4(*):e* Niroomand & Jalili 
   
 
4 Copyright © 2019 Tehran University of Medical Sciences  
This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). 
 
abdominal pain, nausea, and vomiting. Depletion of 
hepatic glycogen stores, increased lipolysis in 
peripheral tissues, and increased production of 
ketones (24). On the other hand, dehydration from 
vomiting leads to decreased renal perfusion, which 
in turn decreases ketone body clearance. 
Dehydration also increases the concentration of 
CRHs, which further enhance lipolysis and 
ketogenesis. Physical examination reveals a  
conscious patient with tachycardia, hypotension, 
increased respiratory rate, and generalized 
abdominal tenderness (without peritoneal signs).  
Features of dehydration or even early stages of 
acute alcohol withdrawal may be present 
concomitantly. In AKA patients, serum glucose 
levels are normal, and may even be low. A wide 
anion gap metabolic acidosis is almost invariably 
present. Since patients usually stop drinking 
because of their symptoms, ethanol levels are 
typically low.  Blood urea and creatinine levels are 
normal or moderately elevated. Urine and serum 
analysis usually reveals ketones. Lactic acidosis 
may accompany anion gap metabolic acidosis. 
However, the lactate level is insufficiently high to 
explain extent of acidosis. While tests for 
ketonemia and ketonuria are positive, a negative 
test does not exclude AKA (24, 25). In the presence 
of high levels of NADH, acetoacetate is converted to 
hydroxybutyrate. Nitroprusside test is able to 
detect acetoacetate but not hydroxybutyrate. 
Hydroxybutyrate to acetoacetate ratio is usually 
8:1 compared to DKA where the ratio is 3:1 (24-
26). 
Differentiation between EuDKA, SKA, and AKA 
should be based on a history, physical examination, 
as well as laboratory data (Table 1). Unlike DKA, 
AKA patients often have almost normal level of 
conscious in spite of a marked acidosis. Free fatty 
acids level is higher in AKA as compared to SKA. 
The level of ketonaemia in SKA appears to be 
relatively mild as compared to ketonemia observed 
in DKA or AKA. In cases of SKA serum bicarbonate 
concentration is usually higher than 18 mEq/L (5, 
7, 16, 22, 27). 
In addition to the above-mentioned conditions, 
other causes of wide anion gap metabolic acidosis 
such as lactic acidosis, tricyclic antidepressant 
overdose, salicylate overdose, and renal tubular 
acidosis should also be distinguished from EuDKA 
(5, 13, 28).  
Treatment 
If diagnosed early and management started 
aggressively, EuDKA may be easily reversed and 
the risk of morbidity and mortality minimized (7).  
In general, EuDKA is managed more or less the 
same way as DKA except that it requires lesser dose 
and duration of insulin treatment. The cornerstone 
of management of EuDKA is rapid correction of 
dehydration with intravenous fluids (13). The next 
step in the treatment of EuDKA is the 
administration of insulin drip together with a 
dextrose-containing fluid until the normalization of 
anion gap and bicarbonate levels. Since relatively 
high doses of insulin are required to reverse the 
severe acidosis in EuDKA patients, higher 
concentrations of dextrose (10 or 20%) are needed 
to allow concomitant administration of large 
amounts of insulin (13, 29, 30).  Adequate glucose 
must also be administered to restore normal 
cellular utilization and correct ketoacidosis (13, 
30). Adequate hydration could prevent 
hyperglycemia in the presence of ketoacidosis by 
enhancing renal excretion of glucose and 
decreasing counter-regulatory hormone release 
(7).  There is often no need for intravenous 
bicarbonate administration because acidosis 
usually improves with restoration of serum 
bicarbonate (13, 29, 30). In a subset of patients 
who are apparently not in a state of insulin 
deficiency and the ketoacidosis is primarily from 
starvation resulting in ketoacids production, an 
approach with IV fluids treatment with close 
monitoring can be attempted with less risk of 
hypoglycemic episodes (4, 30). 
DISCUSSION  
Table 1: Laboratory values in various causes of ketoacidosis 
Variable Diabetic ketoacidosis Euglycemic DKA Alcoholic ketoacidosis Starvation ketoacidosis 
Anion gap High High High ± Lactic acidosis High 
Serum bicarbonate Very low (even <10) Low (<18) Very low (even <10) > 18 
Plasma glucose High Normal to high (<200mg/dl) Normal to low Low 
Urine ketone Present Present Absent or present Present 
Ketonemia  Present Present present Mildly Present 
Serum osmolality Variable Normal Normal Normal 
Free fatty acid level High High Very High High 
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There are several reports on patients with diabetic 
ketoacidosis in whom the serum glucose level is not 
elevated. The pathophysiologic basis of this 
condition has been extensively discussed in the 
literature, but the exact mechanism is yet to be 
determined. Many newer findings, including the 
observation that EuDKA may be seen in diabetic 
patients taking SGLT2 inhibitors, have helped us 
understand the possible mechanisms behind this 
disease. In summary, depletion of glycogen stores 
in the liver following starvation or urinary loss of 
glucose, slows the hyperglycemic phase of diabetic 
ketoacidois, while lipolysis and production of the 
ketone bodies continues. This results in a state of 
ketoacidosis without marked hyperglycemia. 
Diagnosis of EuDKA requires a high index of 
suspicion on the clinician’s side and measurement 
of the presence of ketones in the plasma and urine. 
EuDKA is principally a diagnosis of exclusion and 
several conditions should also be considered. 
These include AKA and SKA. SKA may overlap with 
EuDKA. History, physical examination, and 
laboratory values may help differentiate these 
disease states. While diagnosed, treatment should 
be instituted promptly and meticulously.  
Hydration with intravenous fluids together with 
insulin is the mainstay of treatment.  
CONCLUSIONS 
EuDKA is an endocrine emergency with mortalities 
as high as DKA. Clinicians should keep a high index 
of suspicion for this diagnosis when evaluating a 
diabetic patient with ketoacidosis, especially those 
taking SGLT2 inhibitors.    
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